跳至主要内容
临床试验/ISRCTN16169610
ISRCTN16169610进行中(未招募)未知

Investigating pro-inflammatory B-lymphocyte responses in nasal polyps to interleukin-5

Queen Mary University of London0 个研究点目标入组 28 人开始时间: 2024年6月26日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Patients undergoing resection of nasal tissue for clinical indications (e.g. polypectomy, turbinectomy, septoplasty, tonsilectomy)
  • 2. Able to give consent
  • 3. Aged 18 years and over
  • The researchers will specifically recruit the following subgroups:
  • 1. Patients undergoing nasal polyp resections, who are not on biologics
  • 2. Patients undergoing nasal polyp resections, who are on anti-IL-5 biologics
  • 3. Patients undergoing nasal operations other than polyp resection

排除标准

  • 1. Inability to give consent
  • 2. Previous rituximab treatment (ever)
  • 3. Chemotherapy with preceding 6 months
  • 4. Cystic fibrosis
  • 5. Pregnancy or breastfeeding
  • 6. Known current COVID infection/TB infection

研究者

相似试验